J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target Results could cast shadow over other experimental therapies aimed at the protein tau

https://www.statnews.com/2025/11/24/alzheimers-disease-johnson-and-johnson-posdinemab/ By Damian Garde and Jason MastNov. 24, 2025